Huntington’s Disease Research-2017 Feb
in 2017, Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target BACKGROUND: Focus on the CB2 receptor as a promising pharmacological target in a number of neurodegenerative diseases. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288380/